Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
BMC Medicine 2015, 13:211 (4 September 2015)
In a systematic review and meta-analysis, nearly a quarter of patients undergoing anti-CTLA-4 cancer treatment develop immune-related adverse events, suggesting better knowledge of side effects can reduce morbidity and therapy cessation.
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life
BMC Medicine 2014, 12:120 (17 July 2014)
This article is part of a collection on
Medicine for Global Health...
An increased ratio of blood monocytes to lymphocytes (ML) in South African infants aged 3 to 4 months is associated with tuberculosis (TB) risk in the first two years of life, suggesting the ML ratio may help identify at-risk infants.